Willardiine

From WikiMD's WELLNESSPEDIA

Willardiine is a chemical compound that is used as a selective agonist for the AMPA and kainate receptors, two types of ionotropic glutamate receptors in the brain. It is named after the American chemist Robert Willard, who first synthesized it in the 1960s.

History[edit]

Robert Willard first synthesized Willardiine in the 1960s. The compound was initially studied for its potential use in agriculture, but its effects on the nervous system were soon recognized. Since then, it has been used as a tool in neuroscience research to study the function of glutamate receptors.

Structure and Properties[edit]

Willardiine is a derivative of uracil, one of the four nucleobases in the nucleic acid of RNA. It has a pyrimidine ring structure, with two carbonyl groups at the 1 and 3 positions, and an amino group at the 4 position. The 2 position is substituted with a side chain, which can vary to produce different analogs of Willardiine.

Biological Activity[edit]

Willardiine acts as a selective agonist for the AMPA receptor and kainate receptor, two types of ionotropic glutamate receptors. These receptors are involved in fast synaptic transmission in the central nervous system. By activating these receptors, Willardiine can mimic the effects of glutamate, the main excitatory neurotransmitter in the brain.

Uses[edit]

Willardiine and its analogs are primarily used in neuroscience research. They are used to study the function of AMPA and kainate receptors, and to investigate the role of these receptors in neurological and psychiatric disorders. Some analogs of Willardiine have also been investigated for their potential use in the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

See Also[edit]

References[edit]

This article is a stub related to chemistry. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss blog | Philadelphia weight loss blog | Sleep medicine and sleep apnea services | W8MD MedSpa and wellness | Weight loss prescriptions

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.